These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4835358)

  • 41. Central monoamines and hyperkinase of childhood.
    Shetty T; Chase TN
    Neurology; 1976 Oct; 26(10):1000-2. PubMed ID: 986582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acid monoamine metabolites of cerebrospinal fluid in meningitis and encephalitis.
    Bakke OM; Guldberg HC; Schreiner A
    Acta Neurol Scand; 1974; 50(2):146-52. PubMed ID: 4835617
    [No Abstract]   [Full Text] [Related]  

  • 44. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of baclofen on cerebrospinal-fluid levels of 5-hydroxyindoleacetic acid and homovanillic acid.
    Walinder J; Wallin L; Carlsson A
    N Engl J Med; 1977 Feb; 296(8):452-3. PubMed ID: 834217
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders.
    Banki CM
    J Neurochem; 1977 Jan; 28(1):255-7. PubMed ID: 833600
    [No Abstract]   [Full Text] [Related]  

  • 47. Similar effects of tryptophan and sleep on cisternal cerebrospinal fluid 5-hydroxyindoleacetic and homovanillic acids in cats.
    Radulovacki M; Buckingham RL; Chen EH; Kovacević R
    Brain Res; 1977 Jul; 129(2):371-4. PubMed ID: 884510
    [No Abstract]   [Full Text] [Related]  

  • 48. Difference in neurotransmitter metabolism in frontotemporal-lobe contusion and diffuse cerebral contusion.
    van Woerkom TC; Teelken AW; Minderhous JM
    Lancet; 1977 Apr; 1(8015):812-3. PubMed ID: 66617
    [No Abstract]   [Full Text] [Related]  

  • 49. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of a child with familial dysautonomia.
    Andersson H; Hagne I; Roos BE
    Acta Paediatr Scand; 1973 Jan; 62(1):46-8. PubMed ID: 4691255
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of high-performance liquid chromatographic, gas chromatographic--mass spectrometric, and fluorometric methods for the determination of homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
    Anderson GM; Bowers MB; Roth RH; Young JG; Hrbek CC; Cohen DJ
    J Chromatogr; 1983 Oct; 277():282-6. PubMed ID: 6196374
    [No Abstract]   [Full Text] [Related]  

  • 51. Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.
    Curzon G; Kantamaneni BD; Bartlett JR; Bridges PK
    J Neurochem; 1976 Mar; 26(3):613-5. PubMed ID: 4585
    [No Abstract]   [Full Text] [Related]  

  • 52. The effects of reserpine, L-dopa and 5-hydroxytryptophan on 5-hydroxyindoleacetic and homovanillic acids in cerebrospinal fluid, behaviour and EEG in cats.
    Buckingham RL; Radulovacki M
    Neuropharmacology; 1976 Jul; 15(7):389-92. PubMed ID: 1086441
    [No Abstract]   [Full Text] [Related]  

  • 53. Increase of 5-hydroxyindoleacetic acid and homovanillic acid in cisternal fluid of cats subjected to stress.
    Griauzde M; Radulovacki M
    J Neurochem; 1976 Jun; 26(6):1301-2. PubMed ID: 932735
    [No Abstract]   [Full Text] [Related]  

  • 54. Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in hypersomnia with periodic apneas or idiopathic hypersomnia: preliminary results.
    Baruzzi A; Cirignotta F; Coccagna G; Calderini G; Lugaresi E
    Sleep; 1980; 3(3-4):247-9. PubMed ID: 6164086
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
    Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease.
    Gottfries CG; Kjällquist A; Pontén U; Roos BE; Sundbärg G
    Br J Psychiatry; 1974 Mar; 124(0):280-7. PubMed ID: 4836896
    [No Abstract]   [Full Text] [Related]  

  • 57. Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in adults with attention deficit disorder, residual type.
    Reimherr FW; Wender PH; Ebert MH; Wood DR
    Psychiatry Res; 1984 Jan; 11(1):71-8. PubMed ID: 6200893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis.
    Claveria LE; Curzon G; Harrison MJ; Kantamaneni BD
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):715-8. PubMed ID: 4844138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain monoamine metabolites and tryptophan in ventricular CSF of patients with spasm after aneurysm surgery.
    Vapalahti M; Hyyppä MT; Nieminen V; Rinne UK
    J Neurosurg; 1978 Jan; 48(1):58-63. PubMed ID: 619025
    [No Abstract]   [Full Text] [Related]  

  • 60. Monoamine metabolites in ventricular and lumbar CSF of patients with brain tumors. HPLC and clinical application (II).
    Ikeda Y; Nakazawa S
    Nihon Ika Daigaku Zasshi; 1981 Oct; 48(5):704-7. PubMed ID: 6175655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.